Cryo-Cell International Profit Margin

Cryo-Cell International posts a profit margin of -9.05% as of August 2026. That compares with 1.26% in the prior-year period — down 819.4% year over year. That is below the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cryo-Cell International's profit margin was 1.26%. The latest reading is -9.05% — a 819.4% year-over-year decrease (period ending August 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. Cryo-Cell International's -9.05% is lower that level. That is roughly 142.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Cryo-Cell International's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -9.05% as of August 2026; use YoY and peer views to separate noise from signal.

Context for CCEL's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; Cryo-Cell International's other metric pages and overview cover the third.